What disease is cycloserine used to treat?

Cycloserine (Cycloserine) is a broad-spectrum antibiotic mainly used to treat tuberculosisdisease, especially multidrug-resistant tuberculosis (MDR-TB) and drug-resistant tuberculosis strains. Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis. Traditional treatment mainly relies on first-line drugs such as isoniazid and rifampin. However, with the emergence of drug-resistant strains, treatment regimens have become increasingly complex, and cycloserine has played a key role as a second-line drug.

Cycloserine achieves bactericidal effects by inhibiting key enzymes in the synthesis of Mycobacterium tuberculosis cell walls and destroying the formation of bacterial cell walls. Its mechanism of action is different from that of first-line drugs, so it can effectively bypass the resistance mechanism in the treatment of drug-resistant tuberculosis. Especially when bacteria are resistant to isoniazid and rifampicin, cycloserine provides a valuable treatment option.

In addition to tuberculosis, cycloserine is used in some cases to treat other infections caused by susceptible bacteria, but this is not its primary indication. Modern clinical guidelines primarily position it as an important component of MDR-TB treatment regimens. It is often used in combination with other anti-tuberculosis drugs to enhance efficacy and prevent the development of new drug resistance.

The use of cycloserine to treat tuberculosis requires strict medical monitoring and patient cooperation because of its high risk of side effects, especially its significant impact on the nervous system. In modern treatment, doctors will carefully formulate an individualized treatment plan containing cycloserine based on the drug resistance test results and the patient's specific situation.

In addition, cycloserine plays an important role in global anti-tuberculosis control strategies, especially in countries with high drug resistance rates. The tuberculosis treatment guidelines issued by the World Health Organization (WHO) recommend cycloserine as one of the second-line drugs for the treatment of drug-resistant tuberculosis. Despite this, the scientific community is also actively exploring new, safer and more effective anti-tuberculosis drugs with a view to replacing or reducing the use of cycloserine.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine